This is an old revision of this page, as edited by RA0808 (talk | contribs) at 15:40, 17 December 2024 (RA0808 moved page Pipradimadol to Draft:Pipradimadol: Incomplete article, moving to draft space for editor to continue working on it). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:40, 17 December 2024 by RA0808 (talk | contribs) (RA0808 moved page Pipradimadol to Draft:Pipradimadol: Incomplete article, moving to draft space for editor to continue working on it)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Clinical data | |
---|---|
Other names | FU 29-245 |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C24H37ClN2O2 |
Molar mass | 421.02 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Antiserotoninergic agent, antidepressant, analgesic.
See also
References
- Huegi, Bruno S.; Ebnoether, Anton M.; Rissi, Erwin; Gadient, Fulvio; Hauser, Daniel; Roemer, Dietmar; Buescher, Heinz H.; Petcher, Trevor J. (1983). "Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties". Journal of Medicinal Chemistry 26 (1): 42–50. doi:10.1021/jm00355a010.
Opioid receptor modulators | |||||
---|---|---|---|---|---|
μ-opioid (MOR) |
| ||||
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|